|
: SteroidStocks.com Says: (OTCBB:ZARLF) - (OTCBB:INIS) - (OTCBB:LBYE) Are On Steroids!!!
Sep 08, 2010 (M2 PRESSWIRE via COMTEX) --
SteroidStocks.com Says: (OTCBB:ZARLF) Zarlink Semiconductor Inc. ,(OTCBB:INIS) International Isotopes, Inc. and (OTCBB:LBYE) Liberty Energy Corp. are on STEROIDS!
SteroidStocks.com invites all investors to sign up at www.steroidstocks.com to subscribe to our FREE newsletter.
To feature your publicly traded company in our alerts email us at info@steroidstocks.com
aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"-
About Zarlink Semiconductor
Zarlink Semiconductor delivers world-leading, mixed-signal chip technologies for a broad range of communication and medical applications. The companyaEUR(TM)s core capabilities include network timing solutions that manage time-sensitive communication applications over wireless and wired networks, line circuits supporting high-quality voice services over cable and broadband connections, and ultra low-power radios enabling new wireless medical devices and therapies. Serving the worldaEUR(TM)s largest original equipment manufacturers, ZarlinkaEUR(TM)s highly integrated chip solutions help customers simplify design, lower costs and reach market quickly. For more information, visit www.zarlink.com.
NewaEUR(TM)s Today
OTTAWA, CANADA, Sep 08, 2010 aEUR" Zarlink Semiconductor (TSX: ZL)
aEUR" Established and new customers deploying ZarlinkaEUR(TM)s RF (radio frequency) platform in wireless medical devices to improve patient care and lower healthcare costs
aEUR" Over typical seven year operating life, ultra low-power radio consumes the same amount of energy required to power a 40-watt light bulb for just 10 seconds
Zarlink Semiconductor (TSX: ZL) today announced that global medical device manufacturers are designing its new ultra low-power wireless radio platform into a broad range of in-body communication systems. Customers value ZarlinkaEUR(TM)s ultra low-power radio technology, application support and quality expertise as they design wireless medical products supporting innovative monitoring, diagnostic and therapeutic applications to improve patient care and reduce healthcare costs.
The ZL70102 MICS (Medical Implant Communication Services) radio platform is being designed into approved applications, including pacemakers, ICDs (implantable cardiac defibrillators), associated programming and home monitoring equipment, and new devices such as cardiac monitors and neuromodulation systems.
aEURoeThe worldaEUR(TM)s largest medical device manufacturers, as well as emerging companies introducing new technologies to the healthcare market, are deploying our ultra-low power radio platform in a wide range of applications and therapies that help improve patient care,aEUR said Kirk Mandy, President and CEO, Zarlink Semiconductor. aEURoeOur new MICS radio platform strengthens our medical business, by expanding our long-term relationships with customers seeking products that meet the unique performance and standards requirements for in-body communication systems.aEUR
Third Generation In-Body Wireless Technology
ZarlinkaEUR(TM)s third-generation ZL70102 MICS radio platform delivers enhanced wake-up sensitivity over previous solutions to support an extended wireless link between implanted devices and monitoring and programming equipment. ZarlinkaEUR(TM)s medical radio chips are the industryaEUR(TM)s only products designed exclusively to operate in the MICS 402-405 MHz frequency band.
Designed into wirelessly enabled pacemakers, ZarlinkaEUR(TM)s radio chip routinely transmits patient health and device performance data to a home base station. Data is then forwarded to a physicianaEUR(TM)s office. If a problem is detected, the physician schedules a follow-up visit and the two-way RF link is used to adjust device performance. ZarlinkaEUR(TM)s ultra low-power RF technology is also enabling a new range of diagnostics and therapies, including implanted devices used to monitor and treat diabetes, manage chronic pain or lessen the effects of ParkinsonaEUR(TM)s disease.
During surgery to implant medical devices, the extended wireless operating range of the ZL70102 MICS radio solution allows programming equipment to be located outside the sterile operating field. This potentially shortens surgery times and reduces healthcare costs.
The ZL70102 delivers advanced performance to help conserve battery life for wirelessly enabled implanted medical devices. The ZL70102 operates in an extremely low current aEURoesleep modeaEUR until communication is initiated by the base station. When in full operation, the ZL70102 consumes just 5 mA (milliamps) of supply current. Over a typical seven year operating life of an implanted medical device, the ZL70102 will consume the same amount of energy required to power a 40-watt light bulb for just 10 seconds.
aEURoeOur new ZL70102 radio platform solves key power and performance challenges for medical device manufacturers designing advanced in-body communication systems,aEUR said Steve Swift, Senior Vice President and General Manager of ZarlinkaEUR(TM)s Medical Products Group. aEURoeOur expertise in developing high-performance, standards-compliant radio solutions that meet the unique quality standards for devices intended for human implant is helping our customers more easily incorporate wireless capabilities into existing and new devices and applications.aEUR
ZL70102 MICS radio platform available now
ZarlinkaEUR(TM)s ZL70102 MICS radio platform is now available as a single-chip or complete implantable module solution. For information, visit http://www.zarlink.com/zarlink/hs/82_ZL102.htm.
Full product information, including complete data sheets and application notes, is available to registered MyZarlink customers. To register for a MyZarlink account, visit http://www.zarlink.com/zarlink/hs/login.htm. To learn more about ZarlinkaEUR(TM)s medical expertise, go to http://www.zarlink.com/zarlink/hs/Medical.htm.
EditoraEUR(TM)s Note: A high resolution photograph of the ZL70102 MICS radio platform is available at http://www.zarlink.com/zarlink/hs/22649.htm.
aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"
About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients
News Today:
IDAHO FALLS, Idaho, Sept 08, 2010 aEUR" International Isotopes Inc. (OTC Bulletin Board: INIS) announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
INIS submitted a license application to the U.S. Nuclear Regulatory Commission (NRC) in December 2009 for the construction of its planned depleted uranium de-conversion facility, and has been working with the NRC staff as they progress through their review process.
Steve T. Laflin, President and CEO of International Isotopes Inc. said, aEURoeWe are very pleased with the quality of the license application and the progress the NRC team has made reviewing this application. While we remain confident we will be able to support the completion of the NRC review in a timely fashion, we recognize the considerable recent experience URENCO USA has had with its successful NRC licensing and State of New Mexico permitting, and we have entered into a consulting agreement with URENCO USA in order to take full benefit from their experience.aEUR
Under the terms of the agreement, URENCO USA will perform a detailed review of the INIS Integrated Safety Analysis (ISA) that was submitted to the NRC as part of the licensing process and work with INIS in the preparation of the State of New Mexico permits.
Steve Laflin went on to note that, aEURoeWe believe URENCO USAaEUR(TM)s experience and expertise in licensing and permitting will provide us with an opportunity to lower our costs and help us avoid possible schedule delays related to licensing issues during the construction phase of this aEUR~green technologyaEUR(TM) project. This agreement gives us an additional level of confidence in our ability to complete our required licensing in a timely fashion and contain our future operating costs related to licensing to the greatest extent practical.aEUR
Gregory Smith, President and CEO of URENCO USA, noted the agreement is a natural product of his companyaEUR(TM)s experience and its support for INISaEUR(TM)s decision to locate in Lea CountyaEUR(TM)s EnergyPlex. aEURoeWe are pleased to apply our experience to assist INIS through NRC licensing and New MexicoaEUR(TM)s permitting processes so it can enjoy the many benefits of operating in a state that values nuclear energy.aEUR
aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"-
ABOUT LIBERTY:
Liberty Energy Corp (OTCBB:LBYE) is an Independent Oil and Gas Exploration and Production Company dedicated to the sourcing and production of fuel supplies in the United States and Europe.
Headquartered in Houston, Texas, the company has signed agreements to acquire leases and royalties in both Texas and Bulgaria, covering several wells with extensive potential for future development. In Texas, four leases aEUR" Dahlstrom, Ratliff, and two at Lockhart Northeast aEUR" are identified as rich oil and gas sites based around numerous geological pay zones. In North-West Bulgaria, Liberty has acquired royalty rights to a 1,000,000+ acre natural gas property (the A-Lovech exploration block), an area of high quality, low- sulphur natural gas condensate. Through this combined international reach and domestic focus, Liberty Energy is committed to the development of US fuel reserves while seeking out further opportunities for the global energy markets.
News Today:
HOUSTON, Sep 8, 2010 aEUR" Liberty Energy Corp. (OTCBB:LBYE) aEURoeLibertyaEUR or aEURoethe CompanyaEUR) is pleased to announce that it has entered into a multi phased well re-entry program on its Lockhart Lease, Caldwell County, Texas.
The Lockhart Northeast Project in Caldwell County consists of four land tracts containing eight wells (five re-entry wells and three shut-in wells) over two leases. The lease is located over roughly 848 acres and if proven viable holds enough space to house a potential further 282 new wells.
During phase one of the five-stage work-over, the company intends to re-enter (3) wells and the drill out (1) well on the lease. The four wells in question are located on 3 tracts of land know as the Alexander A, housing (1) re-entry well called the #2, the Alexander B, housing 2 shut-in wells called the #1 & #3 and the Anton, housing (1) shut in well called the Anton #1.
The work will enable the company to have (4) wells in production as well as hold the leases by production. Initial work will be followed by a detailed evaluation of the possibility of developing the lease to its full potential.
The company believes it should be able to get a considerable amount of production from the (3) shut-in wells, primarily by swabbing each well, repeatedly if necessary. Furthermore, with the application of acid/fracture jobs and/or far-out perforating (new completion technology) it is projected that the company will be able to increase production and possibly access undeveloped reservoirs that could produce at significant daily rates and overall total production. The company would hope to follow on with a full property development plan, drilling new wells up to a possible 282 wells.
aEURoeWe are very optimistic about the potential of these leases and are currently seeing several companies tying up several thousand acres around our lease. On our initial visit, the wells to be equipped had oil bubbling out of the top of the cap on the casing, which is a great indication of potential production. Our team on the ground informed us that upon opening the valves, the wells were producing barrels of oil within a few minutes. We are hoping to obtain some instant production, and our intention is to use revenues from these existing wells to proceed with developing the field,aEUR commented Ian Spowart, CEO of Liberty Energy Corp.
aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"aEUR"
About SteroidStocks.com
SteroidStocks.com is written and published by SteroidStocks.com employees. Readers are advised that this analysis report is issued solely for informational purposes. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SteroidStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. For additional information, please visit www.steroidstocks.com or e-mail info@steroidstocks.com.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
[ Back To Homepage ]
|
Home
Featured Article Archives
eNews
RSS FEED
